3 results
8-K
EX-99.1
CADL
Candel Therapeutics Inc
28 Nov 23
Cost Associated with Exit or Disposal Activities
9:00am
, the enLIGHTEN™ Discovery Platform, and Key Clinical Readouts for CAN-2409
Decreases workforce by approximately 50% and reduces commercial manufacturing … workforce and expenses associated with enabling commercial readiness of CAN-2409. The Company expects to present initial activity and biomarker data
8-K
CADL
Candel Therapeutics Inc
28 Nov 23
Cost Associated with Exit or Disposal Activities
9:00am
as the enLIGHTENTM Discovery Platform, and reducing the Company’s workforce by approximately 50%, as well as reducing expenses associated with enabling … of 2023 related to severance and healthcare and related benefits costs.
The actions associated with the workforce reduction under the Restructuring Plan
- Prev
- 1
- Next